U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
MEPLAZUMAB
Common Name English
PMZ201501
Code English
HUMANIZED IGG2 MONOCLONAL ANTIBODY, CONSISTING OF THE COMPLEMENTARY DETERMINING REGIONS OF ANTI-CD147 MURINE ANTIBODY AND THE HUMAN FRAMEWORK REGION WITH RESTRICTIVE MUTATION.
Common Name English
Meplazumab [WHO-DD]
Common Name English
PMZ-201501
Code English
KETANTIN
Brand Name English
Code System Code Type Description
NCI_THESAURUS
C172638
Created by admin on Sat Dec 16 15:16:01 GMT 2023 , Edited by admin on Sat Dec 16 15:16:01 GMT 2023
PRIMARY
SMS_ID
300000020971
Created by admin on Sat Dec 16 15:16:01 GMT 2023 , Edited by admin on Sat Dec 16 15:16:01 GMT 2023
PRIMARY
FDA UNII
0EL07E29VQ
Created by admin on Sat Dec 16 15:16:01 GMT 2023 , Edited by admin on Sat Dec 16 15:16:01 GMT 2023
PRIMARY
ACTIVE MOIETY
MEPLAZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966